SCHEMBL4182547

SCHEMBL4182547

FC(F)(F)C(F)(F)C(F)(F)CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28597147 0.90 LMNA (0.33)
SCHEMBL4337634 0.87 LMNA (0.38)
SCHEMBL20848204 0.87 LMNA (0.38)
SCHEMBL810559 0.87 LMNA (0.38)
SCHEMBL4337670 0.87 LMNA (0.38)
SCHEMBL10300018 0.85
SCHEMBL506369 0.77
SCHEMBL24421392 0.76
SCHEMBL24421395 0.76
SCHEMBL2430245 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383898-A1 PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION YIYOU BIOTECH (SHANGHAI) CO., LTD. (CN) 2024-11-21 US disclosed
EP-4393923-A1 PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION Yiyou Biotech (Shanghai) Co., Ltd. (CN) 2024-07-03 EP disclosed
WO-2023115327-A1 PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION 中国药科大学 2023-06-29 WO disclosed
CN-109153653-B Novel compound, photocurable composition, cured product thereof, printing ink, and printed matter using the printing ink DIC株式会社 2022-06-28 CN disclosed
CN-114149428-A Pyridine-fused ring compound and preparation method, intermediate, composition and application thereof 中国药科大学 2022-03-08 CN disclosed
EP-3322293-B1 ARYLOXYPYRIMIDINYL ETHERS AS HERBICIDES FMC CORP (US) 2021-05-19 EP disclosed
CN-111954848-A Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member DIC株式会社 2020-11-17 CN disclosed
WO-2018227012-A9 POLYMER-LIPID MATERIALS FOR DELIVERY OF NUCLEIC ACIDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-11-14 WO disclosed
US-20180206497-A1 ARYLOXYPYRIMIDINYL ETHERS AS HERBICIDES FMC CORPORATION 2018-07-26 US disclosed
EP-3322293-A1 ARYLOXYPYRIMIDINYL ETHERS AS HERBICIDES E. I. du Pont de Nemours and Company (US) 2018-05-23 EP disclosed
US-5433959-A Antisecretory agent such as lansoprazole stabilized by basic inorganic salts TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-07-18 US disclosed
EP-0423748-B1 Stabilized pharmaceutical composition and its production TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1994-08-24 EP disclosed
US-5304325-A Emulsions of fluorochemical, water, surfactant; synthetic blood HEMAGEN/PFC (US) 1994-04-19 US disclosed
WO-1993009787-A1 EMULSIONS CONTAINING ALKYL- OR ALKYLGYLCEROPHOSPHORYL CHOLINE SURFACTANTS AND METHODS OF USE HEMAGEN/PFC (US) 1993-05-27 WO disclosed
EP-0237200-B1 USE OF BASIC INORGANIC SALTS OF MAGNESIUM OR CALCIUM FOR THE STABILISATION OF BENZIMIDAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 1992-07-01 EP disclosed
US-5093132-A Antiulcer benzimidazole derivative with basic alkali metal or alkaline earth metal compound TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-03-03 US disclosed
EP-0446961-A2 Stabilized pharmaceutical composition and its production Takeda Chemical Industries, Ltd. (JP) 1991-09-18 EP disclosed
US-5045321-A Antiulcer compound lansoprazole or omeprazole with magnesium and/or calcium salt; tablets or granules TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-09-03 US disclosed
EP-0423748-A1 Stabilized pharmaceutical composition and its production Takeda Chemical Industries, Ltd. (JP) 1991-04-24 EP disclosed
EP-0237200-A2 Use of basic inorganic salts of magnesium or calcium for the stabilisation of benzimidazole derivatives Takeda Chemical Industries, Ltd. (JP) 1987-09-16 EP disclosed